Clinical Trial Update: Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer [Phase 2, Phase 3]

View source ↗

Summary

Pfizer is conducting the Symbiotic-Lung-04 trial to evaluate PF-08634404 in combination with chemotherapy for adults with extensive-stage small cell lung cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• PF-08634404

Snippet

Sponsor: Pfizer | Conditions: Small Cell Lung Cancer (SCLC) | Phase 2, Phase 3 | Status: RECRUITING